Watch for Three New Antiepileptics

  You'll see three new antiepileptic drugs called Qudexy XR (cue-DEKS-ee), Fycompa (fi-COM-puh), and Aptiom (AP-tee-om).

Qudexy XR (topiramate extended-release) will compete with Trokendi XR as a once-daily alternative to topiramate immediate-release.

These once-daily brands will cost $140 to $560/month for 25 to 200 mg/day...compared to under $30/month for topiramate immediate-release.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote